Letairis / Volibris

Background

NA

Approved applications

LETAIRIS® (ambrisentan) is a prescription medicine to treat pulmonary arterial hypertension (PAH), which is high blood pressure in the arteries of your lungs. LETAIRIS® can improve your ability to exercise and it can help slow down the worsening of your physical condition and symptoms. PAH is a rare and fatal disorder of the arteries in the lungs which also affects the heart. It afflicts approximately 200,000 patients worldwide and can occur at any age.

Therapeutic Area

Pulmonology

Acquisition Date

Dec 2009

Marketer